1.
Mehmood F, Zeeshan M, Umair M, Khan N, Wajid AA, Ali A. IMATINIB IN CHRONIC MYELOID LEUKEMIA: PATIENT-REPORTED SIDE EFFECTS AND THEIR INFLUENCE ON QUALITY OF LIFE: Imatinib in Chronic Myeloid Leukemia. PAFMJ [Internet]. 2018 Oct. 30 [cited 2024 Apr. 20];68(3):466-70. Available from: https://pafmj.org/PAFMJ/article/view/245